title: [Unilateral Solar Maculopathy after Gazing at Solar Eclipse].
abstract: A 43-year-old male patient with unilateral metamorphosia presented after gazing at an eclipse with only one eye. Damage of the macula was demonstrated funduscopically, with OCT and angiography. Six weeks after initial presentation and oral methylprednisolone therapy (40 mg/d for 10 days), the symptoms and the morphological changes decreased. Solar retinopathy is a photochemical alteration of the retina, usually seen after sun gazing. In younger patients, it mostly presents as bilateral solar maculopathy. Some patients exhibit partial or total recovery.
authors.affiliation: Klinik und Poliklinik für Augenheilkunde, Universitätsklinikum Hamburg-Eppendorf (UKE).
authors.forename: J
authors.initials: J
authors.lastname: Mehlan
authors.affiliation: Klinik und Poliklinik für Augenheilkunde, Universitätsklinikum Hamburg-Eppendorf (UKE).
authors.forename: S J
authors.initials: SJ
authors.lastname: Linke
authors.affiliation: Klinik und Poliklinik für Augenheilkunde, Universitätsklinikum Hamburg-Eppendorf (UKE).
authors.forename: L
authors.initials: L
authors.lastname: Wagenfeld
authors.affiliation: Augenarztpraxis am UKE, zentrumsehstärke, Hamburg.
authors.forename: J
authors.initials: J
authors.lastname: Steinberg
mesh_terms: D000284:Administration, Oral; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage; D005126:Eye Burns / Q000209:etiology*; D006801:Humans; D008266:Macula Lutea / Q000293:injuries* / Q000473:pathology*; D008297:Male; D008775:Methylprednisolone / Q000008:administration & dosage; D012164:Retinal Diseases / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology*; D012993:Solar Energy; D016896:Treatment Outcome
chemical_list: D000893:Anti-Inflammatory Agents; D008775:Methylprednisolone